Mobio Interactive
Mobio Interactive is a Singapore-based digital therapeutics company that uses AI-powered facial photoplethysmography and deep neural networks to objectively measure and treat anxiety, depression, and stress, serving health systems, pharmaceutical companies, and payors globally via its AmDTx and DAWN platforms.
- Company typePrivate
- Founded2015
- HeadquartersSingapore, Singapore
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Mobio Interactive does
Mobio Interactive Pte Ltd. is a Singapore-incorporated digital therapeutics company founded in 2015 that builds an AI-native remote patient monitoring and mental wellbeing platform called AmDTx. The platform uses facial photoplethysmography (PPG) captured through the smartphone camera and proprietary deep neural networks, trained on over 3 million biomarker datapoints from 25,000+ individuals across 150+ countries, to objectively quantify psychological stress, anxiety, and depression. Its measure-treat-measure system personalizes treatments based on quantified therapy response and has been clinically demonstrated across multiple randomized controlled trials. Product surface includes the DAWN precision psychiatry module for clinical populations and consumer mindfulness apps (Wildflowers Mindfulness, Am, Actify Mindfulness), all localized in 6 languages.
The company operates a dual business model: direct-to-consumer distribution via iOS and Android app stores under subscription, and a B2B enterprise motion targeting health systems (reducing waitlist symptom severity), pharmaceutical companies (decentralized clinical trials with objective endpoints), and insurance payors (policyholder preventative engagement). Enterprise pricing is quote-based and not publicly disclosed, while consumer distribution relies on product-led growth through app store presence. The platform is compliant with ISO 27001, HIPAA, and GDPR, and uses AWS for encrypted cloud infrastructure. Operating offices span Singapore, Toronto, Delaware, Zurich, and Shanghai, with leadership comprising CEO and Chief Scientist Bechara Saab, CTO Avetis Muradyan, CFO Jon Brilliant, and VP Pharma Christopher Hall.
Mobio Interactive has raised approximately $4.4 million across five disclosed funding rounds since 2017, with investors including SOSV, Chinaccelerator, Verge HealthTech Fund, Creative Ventures, Orbit Startups, and Orbit Ventures, plus a non-dilutive $50,000 from the OPPO Inspiration Challenge in 2023. The most recent $2,000,000 round closed in April 2025. Revenue figures are not disclosed, and the company operates with 11-50 employees.
Mobio Interactive firmographics
Firmographics- Name
- Mobio Interactive
- Legal name
- Mobio Interactive Pte Ltd.
- Website
- https://mobiointeractive.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Mobio Interactive is a Singapore-based digital therapeutics company that uses AI-powered facial photoplethysmography and deep neural networks to objectively measure and treat anxiety, depression, and stress, serving health systems, pharmaceutical companies, and payors globally via its AmDTx and DAWN platforms.
- Ownership category
- akta.pro rank
Mobio Interactive industry classification
Industry- Product category
- Digital Mental Health Therapeutics
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Mental Health Practitioners (except Physicians) (621330)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industries
- DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM), Non-prescription / OTC Digital Therapeutics (HLACANAC)
Keywords
Where Mobio Interactive is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices5 records
Markets served
Mobio Interactive business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- App-based Mental Health Services: Digital therapeutic services delivered through mobile apps (AmDTx, Wildflowers Mindfulness, Am, Actify Mindfulness) providing objective stress measurement and mental health support to end users.
- Enterprise Clinical Solutions: B2B solutions for health systems, pharmaceutical companies (decentralized clinical trials), and payors (policyholder engagement) using the platform's objective endpoints and patient monitoring capabilities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise licensing for health systems, pharma, and payors |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Mobio Interactive product offering
Product offeringCore offering
Mobio Interactive develops and sells the AmDTx AI-native digital therapeutic platform, which uses facial photoplethysmography (PPG) and proprietary deep neural networks to objectively quantify psychological stress and personalize mental health treatments for anxiety, depression, and stress. The platform is delivered to consumers through mobile apps (AmDTx, Wildflowers Mindfulness, Am, Actify Mindfulness) and to enterprises (health systems, pharma, payors) for remote patient monitoring, decentralized clinical trials with objective endpoints, and preventative policyholder engagement.
Product overview
Mobio Interactive offers a unified AI-native digital therapeutic platform called AmDTx, which includes the DAWN precision psychiatry module and multiple mindfulness mobile applications (Wildflowers Mindfulness, Am, Actify Mindfulness). The platform is localized in 6 languages and uses proprietary facial photoplethysmography and deep neural networks to objectively measure and treat mental health conditions (anxiety, depression, stress) across the full severity spectrum. The core platform's measure-treat-measure system is clinically validated across multiple RCTs and serves health systems, pharma companies, and payors.
Differentiator
Problem solved
Functional benefit
Brands
- DAWN: A clinically validated mental health platform for precision psychiatry at scale.
- AmDTx
- Wildflowers Mindfulness
- Am
- Actify Mindfulness
Products and services
- AmDTx
Quantifiable outcome
- Clinically demonstrated to reduce anxiety, depression, and stress across the full severity spectrum of mental illness
- +1 more outcomes
Companies that use Mobio Interactive
Customer profileSegments3 records
Ideal customer profiles4 records
Mobio Interactive technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability5 records
Feature4 records
Mobio Interactive partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Amazon Web Services (AWS)coreAWS provides encrypted cloud hosting for all Personal and Anonymous data storage. MI uses AWS infrastructure for secure data storage compliant with ISO 27001 and HIPAA standards. AWS is the primary cloud infrastructure provider for the platform.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Mobio Interactive competitors and assessment
Company assessmentDirect peers
- Spring Health: Mental-health benefits platform sold primarily to employers and payors with measurement-based care. Closest direct peer on the payor/employer side of Mobio's GTM.
- Akili Interactive: Public digital therapeutics company (EndeavorRx for ADHD) operating a prescription-grade DTx model with clinical trial evidence and a consumer-accessible product surface — directly comparable to Mobio's evidence-driven DTx positioning.
- Lyra Health: Enterprise mental-health benefits platform providing therapy, coaching, and digital tools to employer-sponsored populations. Direct peer in Mobio's payor/enterprise motion, with much larger scale.
- Woebot Health: AI-driven mental-health platform combining conversational AI with clinical protocols for anxiety and depression. Direct peer on the AI-native mental-health intervention axis Mobio competes in.
- Calm: Leading consumer mental-wellness subscription app with an expanding B2B (employer/payor) channel. Comparable on consumer-side subscription model and mindfulness content, though without Mobio's biomarker-grade measurement layer.
- Headspace Health: Combined meditation/wellness consumer app and employer/payor mental-health benefit platform post-Ginger merger. Overlaps directly with Mobio's consumer mindfulness apps and B2B payor/employer sales motion.
- Big Health: Digital therapeutics company behind Sleepio (insomnia) and Daylight (anxiety), with FDA-clearance and clinically validated outcomes. Closest direct comp to Mobio's clinically validated DTx model targeting anxiety and related mental-health conditions.
Emerging players
- Wysa: AI-driven mental-health chatbot platform with both B2C and B2B (employer/health plan) offerings. Comparable emerging AI mental-health product, though focused on conversational CBT rather than biomarker measurement.
- Meru Health: Digital mental-health program combining clinician-led therapy with app-based measurement and coaching. Comparable niche overlap with Mobio's Measure-Treat-Measure concept at smaller scale.
Broad incumbents
- BetterHelp (Teladoc Health): Largest online therapy platform, owned by Teladoc Health. Broad incumbent in tech-enabled mental-health delivery with employer/payor channels; overlaps with Mobio's consumer and enterprise mental-health positioning at significantly greater scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Mobio Interactive social profiles
Digital presenceMobio Interactive compliance and trust
Trust signalCompliance3 records
Mobio Interactive financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mobio Interactive leadership team
Management profileNumber of profiles
Profiles4 records
Mobio Interactive funding detail
Funding detailFunding overview
Funding rounds5 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mobio Interactive M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mobio Interactive
What does Mobio Interactive do?
Mobio Interactive develops and sells the AmDTx AI-native digital therapeutic platform, which uses facial photoplethysmography (PPG) and proprietary deep neural networks to objectively quantify psychological stress and personalize mental health treatments for anxiety, depression, and stress. The platform is delivered to consumers through mobile apps (AmDTx, Wildflowers Mindfulness, Am, Actify Mindfulness) and to enterprises (health systems, pharma, payors) for remote patient monitoring, decentralized clinical trials with objective endpoints, and preventative policyholder engagement.
Is Mobio Interactive a public or private company?
Mobio Interactive is a private company. It is classified as venture growth investor backed and is currently operating.
When was Mobio Interactive founded?
Mobio Interactive was founded in 2015. It employs 11 to 50 people.
Where is Mobio Interactive based?
Mobio Interactive is headquartered in Singapore, Singapore, in the Asia region.
How does Mobio Interactive make money?
Two revenue lines are on record. App-based Mental Health Services are the primary driver. The others are enterprise Clinical Solutions.
Who are Mobio Interactive's main competitors?
Direct peers on record are Spring Health, Akili Interactive, Lyra Health, Woebot Health, Calm, Headspace Health and Big Health. Emerging players are Wysa and Meru Health. BetterHelp (Teladoc Health) is listed as a broad incumbent.
Does Mobio Interactive have an API?
No public API is recorded for Mobio Interactive.
What industry is Mobio Interactive in?
Mobio Interactive's product category is Digital Mental Health Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms. Its NAICS code is 621420 and its SIC code is 7372.